Developmental exposure to bisphenol A increases prostate cancer susceptibility in adult rats: epigenetic mode of action is implicated.

Department of Urology, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Fertility and sterility (Impact Factor: 4.3). 03/2008; 89(2 Suppl):e41. DOI: 10.1016/j.fertnstert.2007.12.023
Source: PubMed

ABSTRACT Similar to the testes, male accessory sex glands are also vulnerable to environmental endocrine disruptors with adverse effects in adulthood. The developing prostate gland isparticularlysensitivetoestrogens,andhigh-dose exposures duringacriticaldevelopmentalwindowresultsinintraepithe- lial prostatic neoplasia (PIN) in adult rodent models. Bisphenol A (BPA), a ubiquitous environmental contaminant leached from plastics and expoxy resins, has estrogenic activity. Although neonatal exposure to environmentally relevant doses of BPA produced no prostate pathology in the adult rat, we asked whether it would sensitize the adult prostate to estrogenic exposures. Relative estrogen levels rise in the aging male and adult estrogen exposures can be carcinogenic to the prostate gland. To test this possibility, newborn rats were exposed to a low dose of BPA (10 mg/kg body weight) or to a low dose (0.1 mg/kg body weight) or high dose 2.5 mg/kg body weight) of estradiol (E) on days 1, 3, and 5 of life. In adulthood (day 90), the animals were given prolonged E exposure with normal levels of testoster- one (T) via T þ E implants or empty capsules for 16 weeks. Prostates were examined histologically at 7 months. Rats treated neonatally to high-dose E with or without adult T þ E had a high PIN incidence and score. Although low-dose neonatal E exposure alone mildly increased the PIN incidence/score, neonatal BPA alone had no pathologic alteration in the aged prostate. However, rats exposed neonatally to BPA followed by T þ E in adulthood showed a significantly higher PIN incidence and score compared with controls, rats exposed only to BPA neonatally, or those given only T þ E in adulthood (1). The PIN incidence and lesions in rats given BPA with adult T þ E appeared similar to rats treated neonatally with high-dose E. Thus, the present findings suggest that an environmentally relevant dose of BPA may increase the susceptibility of the prostate gland to carcinogenesis following additional adult exposures. To determine whether neonatal exposures to estradiol or BPA may be mediated through epigenetic mechanisms, we screened these prostate tissues for global DNA methylation changes. Over 30 gene candidates were cloned that showed consistent methylation changes as a result of neonatal E or BPA exposures. Phosphodisesterase type 4, variant 4 (PDE4D4), the enzyme involved in degrading cAMP and regulating the cellular levels of this key cell-signaling molecule, was identified as a novel imprinted gene (1) .I n normal prostates, the 50 CpG island of PDE4D4 is gradually hypermethylated, and the gene is silenced with aging. Following neonatal BPA or estradiol exposure, PDE4D4 showed early and persistent hypomethylation of its 50 CpG island resulting in elevated PDE4D4 gene expression in the adultprostates.HPCAL,agenethatdrivescAMPproduction, exhibited a specific methylation and expression alteration in neonatal BPA animals with aging. Together, these findings indicate that the prostate epigenome is permanently altered by early exposures to BPA, resulting in changes in gene expression. We hypothesize that this epigenetic alteration may be a molecular underpinning that leads to heightened predisposition to prostate carcinogenesis with aging.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Prenatal exposure to endocrine disrupting compounds (EDCs) has previously shown to alter epigenetic marks.
    Environment International 06/2014; 71C:81-87. · 5.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The distinct roles of estrogen receptors (ERs) related with androgen receptors (ARs) have been proposed in prostate cancer, while the involvement of transforming growth factor-? (TGF-?) has been reported in the progression of prostate cancer. In this study, we examined whether the TGF-? signaling pathway is associated with ER signaling in LNCaP prostate cancer cells, which express ER?, ER? and ARs. We determined whether the exposure to phthalates may induce prostate cancer progression by affecting molecular crosstalk between ER and TGF-? signaling pathways. Cell viability was measured in LNCaP cells by MTT assay following treatment with di-n-buthyl phthalate (DBP). RT-PCR and immunoblot assay were performed to examine the expression levels of cell cycle-related genes and the TGF-? signaling cascade. A mouse xenograft model of prostate cancer was generated, and immunohistochemical and BrdU assay were carried out to determine the effect of DBP in this mouse model. DBP, a type of phthalate, was shown to promote LNCaP cell proliferation by upregulating the gene expression of c-myc and cyclin D1 and by downregulating the expression of p21. DBP significantly reduced the protein expression of p-smad similarly to E2. These regulations caused by DBP were reversed by ICI 182,780, an ER antagonist, indicating that DBP may affect crosstalk between TGF-? and ER signals. In an in vivo mouse model, tumor volume of mice exposed to DBP was increased. Number of cells in S phase of cell cycle was increased by DBP, while expression of p21 protein was reduced in the tissues of DBP-treated mice. These results indicate that DBP may induce the growth of LNCaP prostate cancer by acting on the crosstalk between TGF-? and ER signaling pathways.
    International Journal of Oncology 05/2014; · 2.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bisphenol A (BPA) is a commonly used monomer in various products including bottled water. Numerous studies have reported endocrine adverse effects and neoplasia associated with BPA exposure in animals. However, considerable discrepancies exist among these studies with respect to both the nature of the toxic effects and the threshold dose. In Lebanon, 19-L polycarbonate (PC) bottles of drinking water are widely used in urban areas. The present study aims at assessing BPA human exposure and associated health risks from drinking water in Lebanese. A total of 22 bottled water sources, packaged in PC, were identified from licensed and non-licensed sources. Water samples were analyzed following exposure to sunlight for 72 h. BPA in water was quantified by HPLC, and other potential organic pollutants were screened by GC/MS. Fifty-nine percent of samples showed BPA levels above detection limits (>0.05 ng/mL). The median BPA level was 0.1 ng/mL (range 0.05 to 1.37 ng/mL). The mean BPA level for the total number of samples was 0.169 ng/mL (±0.280). A higher mean BPA level was found in water from licensed companies compared to non-licensed sources, however, not statistically significant. Screening showed the presence of dibutyl-phthalate and dioctyl-phthalate in only two samples. Endocrine disruptors (EDR) are ubiquitous contaminants in bottled water in Lebanon with potential health risk implications. Although estimated exposure levels are below the reference dose (RfD), further studies are needed to quantitate exposure from various sources and to investigate EDR contribution to existing epidemics in the country.
    Environmental Monitoring and Assessment 05/2014; 186(9). · 1.68 Impact Factor

Full-text (2 Sources)

Available from
Aug 27, 2014